뷰노

338220KOSDAQ소프트웨어 개발 및 공급업

50.4 / 100

Reference Date: 2026-07-24

Financial Score15.0 / 40

News Sentiment18.4 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 4.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

VUNO is a pioneer in medical IT, leveraging deep learning to provide innovative solutions such as cardiac arrest prediction, fundus image analysis, and chest X-ray diagnostics. Its key product, VUNO Med-DeepCARS, received FDA Breakthrough Device Designation in 2023 and is actively expanding into the U.S. market. The company is transitioning to a SaaS-based subscription model, with the prognosis and prediction solutions driving the majority of its revenue.

Number of Employees

165people

Average Salary

80.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 12.284.0Point

PBR

2.99Industry Average 0.890.0Point

3.4x industry avg (risky)

ROE

-17.30Industry Average 1.100.0Point

Well below industry avg

Debt Ratio

5.13Industry Average 7.935.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲64.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲40.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -74.0% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 73.8

Positive
국가건강검진도 AI로 판독한다…루닛·뷰노 등 의료AI 시장 주목
국가건강검진에 AI 판독 시스템 도입 추진으로 뷰노 등 관련 의료AI 기업의 성장 기대.
Positive
뷰노, 중동 5개국에 '하티브 P30' 판매계약…글로벌 공략
뷰노의 중동 5개국에 대한 AI 심전도 기기 판매 계약 체결로 글로벌 시장 진출 성공.
Positive
뷰노, 휴대용 심전계 '하티브' 중동 첫 수출…5개국 판매 계약 체결
뷰노의 휴대용 심전도 기기 '하티브'가 중동 지역에서 첫 수출을 성공하며 5개국과 판매 계약을 체결, 글로벌 시장 진출에 긍정적 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 7,700Won52-week high 27,60052-week low 6,940

1-month return4.0Point

1m +4.76% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0